Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Allium sativum L. regulates in vitro IL-17 gene expression in human peripheral blood mononuclear cells

  • Mouna Moutia1, 2,
  • Fouad Seghrouchni3,
  • Omar Abouelazz4,
  • Anass Elouaddari5,
  • Abdellah Al Jahid5,
  • Abdelhalim Elhou6,
  • Sellama Nadifi4,
  • Jamal Jamal Eddine5,
  • Norddine Habti1, 2 and
  • Abdallah Badou4, 6Email author
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201616:377

https://doi.org/10.1186/s12906-016-1365-9

Received: 17 June 2016

Accepted: 9 September 2016

Published: 29 September 2016

Abstract

Background

Allium sativum L. (A.S.) “garlic”, one of the most interesting medicinal plants, has been suggested to contain compounds that could be beneficial in numerous pathological situations including cancer. In this work, we aimed to assess the immunomodulatory effect of A.S. preparation on human peripheral blood mononuclear cells from healthy individuals.

Methods

Nontoxic doses of A.S. were identified using MTT assay. Effects on CD4+ or CD8+ T lymphocyte proliferation were studied using flow cytometry. The effect of A.S. on cytokine gene expression was studied using qRT-PCR. Finally, qualitative analysis of A.S. was performed by HPLC approach. Data were analyzed statistically by one-way ANOVA test.

Results

The nontoxic doses of A.S. preparation did not affect neither spontaneous nor TCR-mediated CD4+ or CD8+ T lymphocyte proliferation. Interestingly, A.S. exhibited a statistically significant regulation of IL-17 gene expression, a cytokine involved in several inflammatory and autoimmune diseases. In contrast, the expression of IL-4, an anti-inflammatory cytokine, was unaffected. Qualitative analysis of A.S. ethanol preparation indicated the presence of three polyphenol bioactive compounds, which are catechin, vanillic acid and ferulic acid.

Conclusion

The specific inhibition of the pro-inflammatory cytokine, IL-17 without affecting cell proliferation in human PBMCs by the Allium sativum L. preparation suggests a potential valuable effect of the compounds present in this plant for the treatment of inflammatory diseases and cancer, where IL-17 is highly expressed. The individual contribution of these three compounds to this global effect will be assessed.

Keywords

Allium sativum Peripheral blood mononuclear cells Anti-inflammation Cytokines Gene expression Cell proliferation Cell toxicity

Background

T cells represent about 70 % of human Peripheral Blood Mononuclear Cells (PBMCs), in addition to monocytes, natural killer “NK” cells and B cells. Among T lymphocytes, CD4+ T cells are subdivided into various subpopulations such as Th1, Th2 and Th17 cells. Each of these subpopulations has its own set of immunological functions, allowed by a specific group of produced cytokines. For instance, Th1 cells are in charge of intracellular pathogen eradication [1, 2]; but are also involved in the progress of autoimmune diseases and chronic inflammatory disorders [3]. They are characterized by high secretion of IFN-γ and IL-2. Th2 cells are implicated in humoral immunity and provide protection against parasites. They are engaged in human allergic inflammation; its initiation, maintenance and amplification [4] via the production of IL-4, IL-10 and IL-13 [4, 5]. Th17 are involved in the clearance of extracellular bacteria and fungi, due to their capacity to recruit and activate Neutrophils [6]. They are known for their production of IL-17A and IL-17 F. However, Th17 cells are also implicated in promoting the pathogenesis of cancer [7], several autoimmune and inflammatory diseases [8]; such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis and contact dermatitis [9, 10]. Our main interest is to identify phyto-molecules capable of regulating specific pro-inflammatory cytokines such as IL-17, which is implicated in various pathological situations including autoimmunity [8] and cancer [7, 9, 10].

Allium sativum L., a member of the Liliaceae family, is used universally as a flavoring agent in traditional medicine and to enhance physical and mental health [1115]. Some reports also showed that a protein fraction of aged A.S. extract enhanced NK cell activity and cytotoxicity of macrophages towards tumor cells [16]. Another study demonstrated that ingestion of A.S. oil modulated the production of T helper cytokines in rat cervical lymph nodes [17]. Accordingly, A.S. and its specific ingredients, organosulphur compounds, are thought to affect the immune system [18].

In this paper, we aimed to assess the immunomodulatory effect of A.S. extract on human peripheral blood mononuclear cells. Doses of A.S., which did not cause cytotoxicty and did not affect cell proliferation, exhibited a marked regulation of the expression of the pro-inflammatory cytokine IL-17, known to be involved in numerous autoimmune and inflammatory diseases.

Methods

A.S. extract preparation

Allium sativum L. “garlic” bulbs were harvested from a botanical garden in the Faculty of Medicine and Pharmacy of Casablanca, Morocco. The plant was identified by a professor of Botany affiliated to the Biology department of the Polydisciplinary Faculty of Safi. A voucher of the plant specimen has been deposited in the herbarium of the department of Botany of the Scientific Institute of Rabat, Morocco under the reference number 97997. One-hundred grams of peeled dry garlic bulbs were mashed and incubated in ethanol (Sigma, USA) for 24 h (twice) at room temperature. Extracts were then concentrated by rotary. The obtained ethanolic extracts were stored at -20C° until use.

Analysis of polyphenols by HPLC

Qualitative analysis of standard phenolic compounds in A.S. ethanolic extract was performed using high performance liquid chromatography (HPLC) type JASCO PU-1580, equipped with a UV detector / Vis type JASCO 875 UV and a data treatment station Azur version 3.0.3.0. The extract was evaporated to dryness at 40 °C and then taken up with a mixture of distilled water - acetonitril (88–12 %). After vigorous stirring, mixtures were filtered by passing the solution through Whattman nylon membrane. Analysis conditions used were: Column: C18 (1.7 μm 2,1 × 150 mm), UV Wavelength: 285 nm, 1 ml / min, gradient elution program was set as water /acetonitrile (88–12 %). The solution of the polyphenol mixture: Catechin, rutin, vanillin, vanillic acid, caffeic acid, syringic acid and ferulic acid was prepared by dissolving 1–5 mg of each polyphenol in 1 ml of the acetonitril - water 12–88 %. The final solution was filtered through a Whattman nylon membrane 0.22 μm.

PBMC preparation and cell culture

Peripheral blood mononuclear cells “PBMCs” were separated from fresh venous blood collected from healthy donors as previously described [19]. PBMCs isolation was performed by centrifugation on Ficoll- histopaque 1077 (Sigma, USA), at 900 g for 25 min at 18–20 °C, then washed three times by centrifugation, and suspended in RPMI 1640 media (sigma, USA) with L-glutamine supplemented with 10 % heat inactivated newborn calf serum (sigma, USA), 26.3 g/l penicillin and 4.2 g/l streptomycin. Cells were counted using a hemocytometer and standard Trypan blue exclusion method and observed under microscopy. Cells were harvested in plat culture at 37 °C in a humid atmosphere containing 5 % CO2 (Heracell 150i incubator CO2, Thermosciences, France) with different doses of A.S. preparation, with or without 5 μg/ml of phytohaemagglutinin (PHA; Sigma, USA) or plat bound monoclonal anti-CD3 (Okt3, 0.1 μg/ml).

MTT assay

Cytotoxicity of A.S. extract to PBMCs was evaluated by MTT (3-(4, 5 dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide) assay [19, 20]. The test was performed in 96-well plates (Hiwaka, Japan). Triplicate cultures in 200 μl of cell suspension (105cells/well) were incubated in the presence of different doses of A.S. extract with or without stimulation using PHA or anti-human CD3 Okt3 monoclonal Ab. After 4 days of culture, 20 μl of MTT solution (5 mg/ml, Sigma, USA) was added to the wells and incubated for additional 4 h under the same conditions. After removing the plates and centrifuging them at 800 × g for 20 min, supernatant was removed and blue formazan crystals were solubilized by adding 100 μl of DMSO (Sigma, USA) under agitation. Optical Density of cells with A.S. extract was compared to that of control cells. Low optical density readings reflected low coloration intensity, due to the inability of non-viable cells to metabolize MTT salts.

Proliferation assay

PBMCs (106cell/ml) were harvested in 96-well plates. A.S. extract was used at final concentrations of 1 and 2 μg/ml, with or without PHA and with or without anti-CD3 (Okt-3). Cells were labeled before culture with 5, 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) (Sigma, USA) at a concentration of 5 μM, according to a previous paper [21]. Afterward, labeled cells were washed twice with RPMI containing 5 % heat inactivated newborn calf serum. After 4 days of culture, PBMCs were labeled with Anti-CD4 (PrCP, BDBiosciences, France) and anti-CD8 (APC BD Biosciences, France), in order to evaluate proliferation of CD4+ and CD8+ lymphocyte subsets. Analyses were performed using FACS (BD FACSCalibur Flow Cytometer, BD Biosciences, France) and FlowJo software (Ashland, USA). One hundred thousand events were analyzed per sample.

Gene expression quantification by RT-qPCR

Total RNA isolation

TRIzol (Sigma, France) was used to isolate total ARN from cells cultured for 18 h with different doses of A.S. extract in the presence or absence of PHA. Isolated RNA was solubilized in DEPC Treated Water (Invitrogene, France) and measured with spectrophotometer (NanoVue™ Plus Spectrophotometer GE Healthcare UK Limited, UK).

Reverse Transcription (RT)

0.5 μg of total ARN was used to synthesize cDNA using M-MLV reverse transcriptase (Reverse Transcriptase Super Scripte III, 10000 units, Invitrogene, France) in a 20 μl reaction mixture according to the manufacturer’s instructions. 1 μl of oligo dT20 (50 μM) and 1 μl of dNTP (10 mM of each) were added and the mixture was incubated at 65 °C for 5 min to break the secondary structure of RNA; and then put on ice for 5 min. 4 μl of 5X Reverse Transcriptase buffer, 1 μl de DTT (100 mM), 1 μl of RNase Inhibitor (RNasin OUT 5000 units, Invitrogene, France) and 1 μl of M-MLV reverse transcriptase were subsequently added and the mixture was incubated at 50 °C for 60 min, then 70 °C for 15 min.

Real-time PCR assays

Amplifications were performed using Syber® Green PCR Master mix (Applied Biosystems™, life Technologies, France) as recommended by the manufacturer’s manual. Using primers at 500nM for all genes, PCR was programmed as follows: 10 min at 95 °C for polymerase activation and sample denaturation; then 40 cycles of 15 s at 95 °C and 60 s at 60 °C for annealing and extension. Relative quantification of gene expression was analyzed by real-time PCR using real time Fast 7500 (Applied Biosystems™). β-actin was used as internal control. Primers used are as follows; β-actin: forward GAGATGGCCACGGCTGCTT, reverse GCCACAGGACTCCATGCCCA (transcript size: 446 bp), IL-17: forward ATCTCCACCGCAATGAGGAC, reverse: GTGGACAATCGGGGTGACAC (transcript size: 77 bp), IL-4: forward ATGGGTCTCACCTCCCAACTGCT, reverse GTTTTCCAACGTACTCTGGTTGGC (transcripts size: 506, 357, 405 bp) and IFN-γ forward GAAGAATTGGAAAGAGGA, reverse CGACAGTTCAGCCATCAC (transcript size: 265 bp). Fluorescence readings at the end of the extension phase of each cycle were used to estimate the values for the threshold cycles (Ct). The Ct values for each gene were converted into relative quantification (2-ΔΔCt) using the machine 7500 v2.0.6 software. Samples of untreated and unstimulated cells were used as a calibrator for unstimulated treated cells samples. On the other hand, untreated stimulated samples were used as a calibrator for stimulated and treated cell samples. PCR negative control (with no template) was included for each pair of primers.

Statistical analysis

All data were expressed as means +/− standard deviations. Groups were compared using one-way ANOVA followed by Bonferroni’s Multiple Comparison test, with a level of significance set at p < 0.05. GraphPad Prism 5.0 software was used for all statistical analyses.

Results

Evaluation of the cytotoxicity of Allium sativum preparation to human PBMCs

In order to assess the immunomodulatory effect of the A.S. preparation, we started by evaluating cell toxicity of different doses of A.S.. Human PBMCs were treated with increasing doses of A.S. extract in the presence or the absence of stimulation (PHA or anti-CD3 mAb). Figure 1a shows that A.S. extract was not toxic to PBMCs at doses ranging between 0.5 and 4 μg/ml. On the other hand, A.S. extract was found not toxic to PBMCs stimulated with PHA up to certain doses (0.5 to 2 μg/ml). However, 4 μg/ml exhibited a significant toxicity to cells as shown in Fig. 1b. Similar pattern was observed with cells stimulated with anti-CD3 mAb (Fig. 1c). As a result, we concluded 4 μg/ml as a significantly toxic dose of A.S. extract to stimulated human PBMCs.
Fig. 1

Assessment of Allium sativum preparation cytotoxicity on human PBMCs. Human PBMCs were cultured for 4 days in the absence (cntrl-) or the presence of different doses of Allium sativum extract (a). In another series of experiments, PBMCs were left untreated or were treated with A.S. extract in the presence of PHA (b) or Okt-3 mAb (c). 4 days later, MTT assay was performed to evaluate cytotoxicity. Experiments shown in a, b and c are representative of five, five and three independent experiments respectively. Data were analyzed using one way ANOVA test. (*, **) indicate P values of less than 0.05 and 0.01 respectively

Effect of Allium sativum preparation on PBMC Proliferation

Subsequently, we tested the effect of the non toxic doses of A.S. extract on human PBMC proliferation by using CFSE combined to flow cytometry. To test whether A.S. is able to induce PBMC (more specifically CD4+ and CD8+ T lymphocytes) proliferation in the absence of mitogenic stimulation, unstimulated CFSE-labeled PBMCs were incubated with A.S. preparations at two doses (1 and 2 μg/ml) for 96 h. Our results showed that A.S. did not affect significantly T lymphocyte proliferation at the non toxic doses tested (Fig. 2 a, b, c, j, k, l; and Additional file 1: Figure S1a and c). In order to test whether A.S. is able to inhibit or enhance PHA or anti-CD3 –stimulated CD4+ and CD8+ T cells proliferation, CFSE-labeled PBMCs were stimulated by PHA or anti-CD3 mAb (Okt-3), in the absence or presence of A.S. extract (Fig. 2 d, e, f, m, n, o, g, h, i, p, q, r; and Additional file 1: Figure S1 a, b, c et d). These data showed that A.S. did not affect significantly CD4+ or CD8+ T lymphocyte proliferation.
Fig. 2

Effect of Allium sativum extract on human PBMCs proliferation. Panels from a to i show an example of data generated by CFSE and anti-CD4 stained PBMCs. Panels from j to r show an example of data generated by CFSE and anti-CD8 stained PBMCs. Cells were cultured in different conditions of stimulation and treated with two doses of Allium sativum (A.S.) extract for 4 days. a and j untreated PBMCs b and k, c and l PBMCs treated with A.S. extract at 1 and 2 μg/ml respectively. d and m PBMCs stimulated with PHA. e and n, f and o cells were stimulated with PHA and treated with A.S. extract at 0.5 and 1 μg/ml respectively. g and p cells were stimulated with Okt-3 mAb at 0.1 μg/ml. h and q, i and r PBMCs stimulated with Okt-3 mAb and treated with A.S. extract at 1 and 2 μg/ml respectively. Each peak represents a cycle of cell division. The curves generated by the CFSE profile were analyzed using the proliferation platform of the FlowJo software. Data shown represent results of 4 independent experiments. IP indicates index of proliferation calculated with FlowJo software

Significant regulation of IL-17 gene expression by Allium sativum

To assess the effect of Allium sativum on pro- and anti-inflammatory cytokine gene expression, we treated PBMCs from healthy donors, for 18 h, with non toxic doses of A.S. preparation with or without PHA stimulation. Results in Fig. 3a indicate that a single treatment with A.S. extract stimulated significantly the expression of the pro-inflammatory cytokine, IL-17. We could detect an increased expression of IL-17 gene in 4 out of 6 donors tested. In all these 4 donors, we have observed an increase in IL-17 transcripts upon treatment with A.S.. Interestingly, when PBMCs were stimulated with PHA, treatment with A.S. showed a significant and dose dependent decrease in IL-17 gene expression (Fig. 3b). On the other hand, we could not detect any statistically significant effect of A.S. on IL-4 gene expression (known to be an anti-inflammatory cytokine), either in the absence (Fig. 3c) or presence (Fig. 3d) of a T lymphocyte activator such as PHA. It is to note that a trend of increase in IL-4 gene expression was observed in some donors both in the absence (Fig. 3c) and the presence (Fig. 3d) of PHA, but this effect was not significant. We also tempted to quantify the expression of IFN-γ gene in our experiments, but we could not detect its expression in our tested donors (data not shown); and thus no conclusions could be drawn for this cytokine. Altogether, these data suggested that A.S. preparation exhibited a significant regulation of IL-17 gene expression and that this effect would depend on the activation state of T lymphocytes.
Fig. 3

Effects of Allium sativum extract on IL-17 and IL-4 gene expression in PBMCs. IL-17 (a) and IL-4 (c) transcripts were evaluated in PBMCs treated with two doses of A.S. IL-17 (b) and IL-4 (d) transcripts were assessed in PBMCs stimulated with PHA in the absence or presence of two doses of A.S.. Data were represented in mean ± S.D. Data were analyzed using the one-way ANOVA test. (*, ***) indicate P values of less than 0.05 and 0.001 respectively. Data shown in a, b, c and d are representative of four, three, five and five independent experiments respectively

Analysis of polyphenols and flavonoids in Allium sativum extract by HPLC

With the aim of identifying the bioactive compounds of Allium sativum extract responsible for the observed effect, A.S. ethanolic preparation was analyzed by HPLC at 285 nm, to determine the presence of polyphenols and flavonoids. A mixture of seven standards was used in this experiment. Interestingly, three compounds, catechin, vanillic acid and ferulic acid, were identified from the extract by matching their retention time against those of the standards. Peak assignment was confirmed by injection of standards. Figure 4a shows the HPLC chromatogram of a mixture of 7 polyphenol standards for peak comparison with the chromatogram of the A.S. extract (Fig. 4b). The HPLC chromatogram of A.S extract in Fig. 4b displayed 7 peaks detected at 285 nm. Peaks 1, 2 and 6 were identified as catechin, vanillic acid and ferulic acid, respectively. The chemical structure of each of the identified compounds is elucidated in Fig. 4c.
Fig. 4

a Chromatogram of 7 available polyphenol and flavonoid standards monitored at 280 nm and identified by retention time (minutes) 1: catechin, 2: vanillic acid, 3: cafeic acid, 4: syringic acid, 5: rutin, 6: ferulic acid, 7: vanillin. b HPLC chromatogram of A.S. extract obtained under optimum conditions: 88 % water and 12 % acetonitril, 50 min. Peak no. 1: catechin, 2: vanillic acid and 6: ferulic acid were identified. c The chemical structure of the three identified compounds

To summarize, this study showed that A.S. extract contains compounds, which could be used in non toxic doses and without affecting T cell proliferation, to modulate IL-17 gene expression by significantly stimulating its expression in the absence of prior PBMC activation; and to significantly inhibit its expression when PBMCs are stimulated with a mitogen such as PHA. Interestingly, in the same experimental conditions, A.S. does not affect the expression of the anti-inflammatory cytokine, IL-4. Furthermore, these data showed that our A.S. extract contains 3 polyphenol compounds, catechin, vanillic acid and ferulic acid, which could be responsible for this potentially interesting effect.

Discussion

For many years, A.S. has been acknowledged as an important folk medicine with a favorable effect against a large number of pathologic conditions. In this work, we aimed to evaluate the potential in vitro immunomodulatory effect of A.S., on PBMCs from healthy donors. We started by defining a range of non toxic doses using the MTT assay. These doses were used to evaluate cell proliferation and to quantify pro and anti-inflammatory cytokine gene expression. Our data showed that doses from 0.5 to 2 μg/ml of A.S. ethanolic extract were not toxic to cells under any of the used conditions. The same doses were used to test whether our A.S. extract exhibited any effect on PBMCs proliferation. Our results showed that A.S. extract did not affect neither human CD4+ nor CD8+ T cell proliferation induced by PHA, as shown by flow cytometry, which is consistent with data reported by others [16] when cells were stimulated by PHA. While in the same time, other data showed divergent results. Since Morioka et al. showed that A.S. extract enhanced ConA-induced proliferation of human T lymphocytes [16]. Other data revealed that several organosulfur compounds extracted from A.S. displayed a cell proliferation modulation, such as ajoene that exerted a strong inhibitory effect on PHA, phorbol myristate acetate and anti-CD3 mAb -induced proliferation of human lymphocytes [22, 23]. Colic et al. also demonstrated that a protein fraction from A.S. aqueous extract exhibited an enhancement of T-cell proliferation in mouse splenocyte cultures stimulated with PHA. As further explained in [24, 25], A.S. extracts and their compounds had a dual role on mice and rat T lymphocyte proliferation. In fact, higher concentrations (50 μg/ml) inhibited T cell proliferation triggered by ConA and at lower concentrations (3–12.5 μg/ml) of the extract, amplified the ConA-induced proliferative response of T cells [25]. It was also well demonstrated that aged A.S. extract enhanced the proliferation of spleen cells. Aged A.S. extract slightly improved ConA- induced proliferation of mice spleen cells, but did not increase the effects of the other mitogens, pokeweed mitogen (PWM) and lipopolysaccharides (LPS) [26]. This divergence might depend on different stimulation types, on the cell type used, and the A.S. preparation method used during these experiments.

As for cytokine gene expression, we could not detect any significant effect on IL-4 gene expression. While previous studies reported an increase in IFN-γ and IL-4 production in lymphocytes from rat spleens upon oral A.S. consumption [27]; and an increase in IL-4 when lymphocytes from rat spleens were stimulated by phorbol myristate acetate and treated with aqueous and ethanol preparations made from garlic powder [28]. A.S. powder extracts were found to reduce the level of pro-inflammatory cytokines, IL-1β and TNFα, in human blood sample supernatants, while the expression of the anti-inflammatory cytokine IL-10 was unchanged [29].

Our present study is the first report showing the ability of A.S. compounds to inhibit IL-17 gene expression. The present data showed an inhibition of the pro-inflammatory cytokine, IL-17 gene expression without affecting the anti-inflammatory cytokine IL-4, which might suggest a specific potential regulation of IL-17 that could be useful in controlling several inflammatory and autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and cancer. For example, it was shown that IL-17 plays a pivotal role in the development of central nervous system inflammation in multiple sclerosis, where it was found to correlate with active lesions [30] and to be up-regulated in chronic lesions in multiple sclerosis patients [31, 32]. IL-17 was also shown to be involved in the pathogenesis of rheumatoid arthritis [33]. Indeed, a high level of IL-17 was found in synovium and synovial cultures from rheumatoid arthritis patients [34, 35]. IL-17 appeared to activate and enhance all mechanisms of tissue injury and to up-regulate and/or synergize with local inflammatory mediators such as IL-6 [36, 37], IL-1β and TNF-α [37, 38]. Furthermore, there are suggestions that in pulmonary asthma there are higher levels of intracellular IL-17 and increased numbers of IL-17-producing cells (T lymphocytes and eosinophils in broncheoalveolar lavage) relative to healthy controls both locally and within the circulation [39]. Higher amounts of IL-17 has also been revealed in many different types of human tumors including lymphoma, melanoma, breast, colon, gastric, hepatocellular, pancreatic, ovarian and prostate cancers. Overall, the presence of Th17 cells and/or IL-17 has been reported to be a poor prognostic indicator [40]. Similar observations have also been made in different mouse models of cancer [40]. Wilke et al. explained how IL-17 has become an interesting therapeutic target in many autoimmune diseases [41].

Because there is an ongoing debate concerning whether organosulfur compounds or other constituents such as polyphenols and flavonoids, mediate the protective effect attributed to garlic [29], we carried out a qualitative analysis of the A.S. extract by HPLC. This showed the presence of two phenolic acids “vanillic acid and ferulic acid” and a flavonoid of the flavonols class which is “catechin”. These phenolic compounds are known to have interesting immunomodulatory effects but none of them was tested on the expression of IL-17 from human PBMC. Vanillic acid, which is a benzoic acid derivative and an oxidized form of vanillin formed during the transformation of vanillin to ferulic acid [4244], has been proved to enhance the activity of lymphocyte proliferation and IFN-γ secretion in human PBMCs [45] and to exhibit a hepatoprotective effect by its suppressive action on immune-mediated liver inflammation in ConA-induced liver injury in mouse [44, 46]. As for ferulic acid, it was found to have a chemopreventive activity against coronary heart disease, thrombosis, mutagenesis and carcinogenesis, in addition to an anti-cancer activity against colon and rectal cancer [47]. Catechin is a major compound of flavonoids, which are known for their ability to control lymphocyte proliferation and to modulate IL-2 and IFN-γ secretion in human PBMCs and mouse splenocytes [48]. It was also found that catechin ameliorates cardiac dysfunction, in a rat model of chronic heart failure, by regulating the unbalanced level of IL-17/IL-10 [49].

Conclusion

Allium sativum L. preparation exhibiting a specific inhibition of the pro-inflammatory cytokine IL-17, without affecting cell proliferation in human PBMCs indicates a potential valuable effect of the compounds present in this plant to treat inflammatory diseases and cancer, where IL-17 is highly involved. The individual contribution of these identified compounds to this interesting global inhibitory effect is under investigation and could unravel a pivotal therapeutic role.

Abbreviations

A.S.: 

Allium sativum L.

ARNm: 

ARN messenger

CFSE: 

5, 6-carboxyfluorescein diacetate succinimidyl ester

Con A: 

Concanavalin A

Ct: 

Threshold cycles

IL: 

Interleukin (e.g., IL-4, IL-17)

mAb: 

Monoclonal antibody

MTT: 

3-(4, 5 dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide

PBMCs: 

Peripheral blood mononuclear cells

PHA: 

Phytohaemagglutinin

Th: 

T helper

Declarations

Acknowledgement

We would like to thank Dr. Ouahman Lahcen from the Biology department of the Polydisciplinary Faculty of Safi, Morocco for his help with the identification of Allium sativum L.

Funding

This study has been funded by the ministry of higher education and scientific research, Rabat, Morocco.

Availability of data and materials

Datasets supporting the conclusions of this article are represented in the manuscript and the included Additional files 2, 3 and 4.

Authors’ contributions

MM carried out cell culture, data acquisition, analysis of cytotoxicity assays, cell proliferation, gene expression assays and statistical analysis. FS helped with the CFSE cell proliferation assays. OA helped with the MTT assays. AE, AA and JJ carried out the HPLC analysis. ABE collected A.S. samples and prepared the extract. SN contributed to real time PCR experiments. NH participated in study design and coordination and helped to draft the manuscript. AB conceived the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Authors’ information

MM is a PhD student at the Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco. FS is a researcher and Cellular immunology Laboratory supervisor at the National Institute of Hygiene, Rabat, Morocco. OA is a PhD student at the Cellular and Molecular Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco. ABE is a PhD student at Cadi Ayyad University, Polydisciplinary Faculty - Safi, Morocco. AE and AA are PhD students and JJ is a professor of chemistry at the Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco.

SN is a Professor of Genetics at the Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.

NH is a Professor of Immuno-hematology at the Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco. AB is a Professor of Immunology at the Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable

Ethics approval and consent to participate

Informed consent was obtained from all donors for the use of their blood for scientific research. This study was approved by the ethic committee for biomedical research affiliated to the Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco, under the reference number 0216.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Laboratory of Hematology and Cellular and Genetic Engineering, Faculty of Medicine and Pharmacy, Hassan II University
(2)
Laboratory of Experimental Medicine and Biotechnology, Faculty of Medicine and Pharmacy, Hassan II University
(3)
Laboratory of Cellular Immunology, National Institute of Hygiene
(4)
Cellular and Molecular Pathology Laboratory, Faculty of Medicine and Pharmacy, Hassan II University
(5)
Laboratory of Synthesis, Extraction and Physicochemical Study of Organic Molecules, Faculty of Sciences Ain Chock, Hassan II University
(6)
Research Team Health and Environment, Cadi Ayyad University, Polydisciplinary Faculty

References

  1. Gonzales JR, Groger S, Boedeker RH, Meyle J. Expression and secretion levels of Th1 and Th2 cytokines in patients with aggressive periodontitis. Clin Oral Investig. 2012;16(5):1463–73.View ArticlePubMedGoogle Scholar
  2. Lang A, Lahav M, Sakhnini E, Barshack I, Fidder HH, Avidan B, Bardan E, Hershkoviz R, Bar-Meir S, Chowers Y. Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells. Clin Nutr. 2004;23(5):1199–208.View ArticlePubMedGoogle Scholar
  3. Hirahara K, Poholek A, Vahedi G, Laurence A, Kanno Y, Milner JD, O’Shea JJ. Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. J Allergy Clin Immunol. 2013;131(5):1276–87.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Pulendrani B, Artis D. New paradigms in type 2 immunity. Science. 2012;337:431–5.View ArticleGoogle Scholar
  5. Kaku H, Goldstein IJ, Van Damme EJM, et al. New mannose-specific lectins from garlic (Allium sativum) and ramsons (Allium ursinum) bulbs. Carbohydr Res. 1992;229:347–53.View ArticlePubMedGoogle Scholar
  6. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood. 2010;115:2.View ArticleGoogle Scholar
  7. Singh VK, Singh DK. Pharmacological effects of garlic (Allium sativum L.). Ann Rev Biomed Sci. 2008;10:6–26.Google Scholar
  8. Oukka M. Th17 cells in immunity and autoimmunity. Ann Rheum Dis. 2008;67 Suppl 3:iii26–9.View ArticlePubMedGoogle Scholar
  9. Fouser LA, Wright F, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev. 2008;226:87–102.View ArticlePubMedGoogle Scholar
  10. Kemper K. Garlic (Allium sativum), The Longwood Herbal Task Force and the Center for Holistic Pediatric Education and Research. 2000. p. 49.Google Scholar
  11. Londhe VP, Gavasane AT, Nipate SS, Bandawane DD, Chaudhari PD. Role of garlic (allium sativum) in various diseases: an overview. J Pharm Res Opin. 2011;1(4):129–34.Google Scholar
  12. Banerjee S, Mukherjee P, Maulik S. Garlic as an antioxidant: the good, the bad and the ugly. Phytother Res. 2003;17:97–106.View ArticlePubMedGoogle Scholar
  13. Corzomartinez M, Corzo N, Villamiel M. Biological properties of onions and garlic. Trends Food Sci Technol. 2007;18(12):609–25.View ArticleGoogle Scholar
  14. Suleria HAR, Butt MS, Anjum FM, Sultan S, Khalid N. Aqueous garlic extract; natural remedy to improve haematological, renal and liver status. J Nutr Food Sci. 2013;4:252.View ArticleGoogle Scholar
  15. Lanzotti V. The analysis of onion and garlic. J Chromatogr. 2006;1112(1–2):3–22.View ArticleGoogle Scholar
  16. Pranoto Y, Salokhe V, Rakshit S. Physical and antibacterial properties of alginate based edible film incorporated with garlic oil. Food Res Int. 2005;38(3):267–72.View ArticleGoogle Scholar
  17. Sivam GP. Protection againstHelicobacterpyloriand other bacterial infections by garlic. J Nutr. 2001;131(3):1106s–8.PubMedGoogle Scholar
  18. Ota N, Takano F, Muroga S, Kawabata T, Ishigaki Y, Yahagi N, Ohta T. Garlic extract and its selected organosulphur constituents promote ileal immune responses ex vivo. J Funct Foods. 2012;4(1):243–52.View ArticleGoogle Scholar
  19. Moutia M, El Azhary K, Elouaddari A, Al Jahid A, Jamal Eddine J, Seghrouchni F, Habti N, Badou A. Capparis Spinosa L. promotes anti-inflammatory response in vitro through the control of cytokine gene expression in human peripheral blood mononuclear cells. BMC Immunol. 2016;17(1):26.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Somani SJ, Modi KP, Majumdar AS, Sadarani BN. Phytochemicals and their potential usefulness in inflammatory bowel disease. Phytother Res. 2015;29(3):339–50.View ArticlePubMedGoogle Scholar
  21. Amedei A, Prisco D, D’Elios MM. Multiple sclerosis: the role of cytokines in pathogenesis and in therapies. Int J Mol Sci. 2012;13(10):13438–60.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Amagase H. Clarifying the real bioactive constituents of garlic. J Nutr. 2006;136:716S–25.PubMedGoogle Scholar
  23. Liu JZ, Lin XY, Milner JA. Dietary garlic powder increases glutathione content and glutathione S-transferase activity in rat liver and mammary tissues. FASEB J. 1992;6:A3230.Google Scholar
  24. Chung LY. The antioxidant properties of garlic compounds: allyl cysteine, Allicin and allyl disulfide. J Med Foods. 2006;9:205–13.View ArticleGoogle Scholar
  25. Colic M, Vucevic D, Kilibarda V, Radicevic N, Savic M. Modulatory effects of garlic extracts on proliferation of T-lymphocytes in vitro stimulated with concanavalin A. Phytomedicine. 2002;9(2):117–24.View ArticlePubMedGoogle Scholar
  26. Ide N, Lau BHS. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor -KB activation. J Nutr. 2001;131:1020s–6.PubMedGoogle Scholar
  27. Zamani A, Vahidinia A, Ghannad MS. The effect of garlic consumption on Th1/Th2 cytokines in phytohemagglutinin (PHA) activated rat spleen lymphocytes. Phytother Res. 2009;23(4):579–81.View ArticlePubMedGoogle Scholar
  28. Colic M, Vucevic D, Kilibarda V, Radicevic N, Savic M. Garlic extracts stimulate proliferation of rat lymphocytes in vitro by increasing il-2 and il-4 production. Immunopharmacol Immunotoxicol. 2000;22(1):163–81.View ArticlePubMedGoogle Scholar
  29. Keiss H-P, Dirsch VM, Hartung T, Haffner T, Trueman L, Auger J, Kahane R, Vollmar AM. Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-B activity. J Nutr. 2003;133:2171–5.PubMedGoogle Scholar
  30. Lau BHS. Detoxifying, radioprotective and phagocyte enhancing effects of garlic. Int Clin Nutr Rev. 1989;9:27–31.Google Scholar
  31. Morioka N, Szel LL, Morton DL, Irie RF. A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A. Cancer Immunol Immunother. 1993;37:316–22.View ArticlePubMedGoogle Scholar
  32. Kuttan G. Immunomodulatory effect of some naturally occuring sulphur-containing compounds. J Ethnopharmacol. 2000;72(1–2):93–9.View ArticlePubMedGoogle Scholar
  33. Feng ZH, Zhang GM, Hao TL, Zhou B, Zhang H, Jiang ZY. Effect of diallyl trisulfide on the activation of T cell and macrophage-mediated cytotoxicity. J Tongji Med Univ. 1994;14:142–7.View ArticlePubMedGoogle Scholar
  34. Romano EL, Montaño RF, Brito B, Apitz R, Alonso J, Romano M, Gebrán S, Soyano A. Effects of Ajoene on lymphocyte and macrophage membrane-dependent functions. Immunopharmacol Immunotoxicol. 1997;19:15–36.View ArticlePubMedGoogle Scholar
  35. Dorhoi A, Dobrean V, Zahan M, Virag P. Modulatory effects of several herbal extracts on avian peripheral blood cell immune responses. Phytother Res. 2006;20(5):352–8.View ArticlePubMedGoogle Scholar
  36. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN- g- activated macrophages. J Immunol. 1992;148(6):1792–6.PubMedGoogle Scholar
  37. Larypoor M, Bayat M, Zuhair MH, Akhavan Sepahy A, Masoud A. Evaluation of the number of CD4+CD25+ FoxP3+ Treg cells in normal mice exposed to AFB1 and treated with aged garlic extract. Cell J (Yakhteh). 2013;15:1.Google Scholar
  38. Sela U, Ganor S, Hecht I, Brill A, Miron T, Rabinkov A, Wilchek M, Mirelman D, Lider O, Hershkoviz R. Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression. Immunology. 2004;111(4):391–9.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Ebrahimi M, Hassan ZM, Mostafaie A, Mehrjardi NZ, Ghazanfari T. Purified protein fraction of garlic extractmod- ulates cellular immune response against breast transplanted tumors in BALB/c mice model. Cell J. 2013;15(1):65–74.PubMedPubMed CentralGoogle Scholar
  40. Lau BH, Yamasaki T, Gridley DS. Garlic compounds modulate macrophage and T-lymphocyte functions. Mol Biother. 1991;3:103–7.View ArticlePubMedGoogle Scholar
  41. Nantz MP, Rowe CA, Muller CE, Creasy RA, Stanilka JM, Percival SS. Supplementation with aged garlic extract improves both NK and gd-T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention. Clin Nutr. 2012;31(3):337–44.View ArticlePubMedGoogle Scholar
  42. Ried K, Frank OR, Stocks NP. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial. Maturitas. 2010;67(2):144–50.View ArticlePubMedGoogle Scholar
  43. Morihara N, Ide N, Weiss N. Aged garlic extract inhibits homocysteine-induced scavenger receptor CD36 expression and oxidized low-density lipoprotein cholesterol uptake in human macrophages in vitro. J Ethnopharmacol. 2011;134(3):711–6.View ArticlePubMedGoogle Scholar
  44. Sitia S, Tomasoni L, Atzenietal F. From endothelial dysfunction to atherosclerosis. Autoimmun Rev. 2010;9(12):830–4.View ArticlePubMedGoogle Scholar
  45. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue 13 macrophages recruited during diet-induced obesity. Diabetes. 2007;56(1):16–23.View ArticlePubMedGoogle Scholar
  46. Liu J, Divoux A, Sun J, et al. Genetic deficiency and pharmacological stabilization ofmast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009;15(8):940–5.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Liu C, Cao F, Tang QZ, Yan L, Dong YG, Zhu LH, Wang L, Bian ZY, Li H. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways. J Nutr Biochem. 2010;21(12):1238–50.View ArticlePubMedGoogle Scholar
  48. Quintero-Fabi’and S, Ortu˜no-Sahag’un D, V’azquez-Carrera M, Lopez-Roa RI. Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes. Mediators Inflamm. 2013;2013:11.Google Scholar
  49. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement